↓ Skip to main content

Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective…

Overview of attention for article published in European Journal of Clinical Microbiology & Infectious Diseases, August 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
2 X users

Citations

dimensions_citation
15 Dimensions

Readers on

mendeley
29 Mendeley
Title
Fidaxomicin for the treatment of Clostridium difficile infection (CDI) in at-risk patients with inflammatory bowel disease, fulminant CDI, renal impairment or hepatic impairment: a retrospective study of routine clinical use (ANEMONE)
Published in
European Journal of Clinical Microbiology & Infectious Diseases, August 2018
DOI 10.1007/s10096-018-3344-1
Pubmed ID
Authors

Maria J. G. T. Vehreschild, Surabhi Taori, Simon D. Goldenberg, Florian Thalhammer, Emilio Bouza, Joop van Oene, Graham Wetherill, Areti Georgopali

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 4 14%
Student > Ph. D. Student 3 10%
Researcher 2 7%
Student > Doctoral Student 2 7%
Student > Bachelor 2 7%
Other 3 10%
Unknown 13 45%
Readers by discipline Count As %
Medicine and Dentistry 7 24%
Environmental Science 1 3%
Biochemistry, Genetics and Molecular Biology 1 3%
Arts and Humanities 1 3%
Computer Science 1 3%
Other 3 10%
Unknown 15 52%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 August 2018.
All research outputs
#20,567,353
of 26,017,215 outputs
Outputs from European Journal of Clinical Microbiology & Infectious Diseases
#2,460
of 3,203 outputs
Outputs of similar age
#254,176
of 344,894 outputs
Outputs of similar age from European Journal of Clinical Microbiology & Infectious Diseases
#35
of 53 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,203 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 19th percentile – i.e., 19% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 344,894 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 53 others from the same source and published within six weeks on either side of this one. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.